Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Seronegative myasthenia gravis.

B C Soliven1, D J Lange, A S Penn

  • 1Department of Neurology, Columbia-Presbyterian Medical Center, College of Physicians and Surgeons, Columbia University, New York, NY.

Neurology
|April 1, 1988
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Search for Evidence of Baryogenesis and Dark Matter in B^{+}→ψ_{D}+p Decays at BABAR.

Physical review letters·2023
Same author

Search for an Axionlike Particle in B Meson Decays.

Physical review letters·2022
Same author

Search for Lepton Flavor Violation in ϒ(3S)→e^{±}μ^{∓}.

Physical review letters·2022
Same author

Search for Darkonium in e^{+}e^{-} Collisions.

Physical review letters·2022
Same author

Precision Measurement of the Ratio B(ϒ(3S)→τ^{+}τ^{-})/B(ϒ(3S)→μ^{+}μ^{-}).

Physical review letters·2021
Same author

Search for a Dark Leptophilic Scalar in e^{+}e^{-} Collisions.

Physical review letters·2020
Same journal

Phenotype, Severity, and Therapy of Patients With LRP4 Antibody-Associated Myasthenia Gravis in the German Myasthenia Gravis Registry.

Neurology·2026
Same journal

Association of Changes in Intrinsic Capacity With Cognitive Decline and Dementia: A Prospective Cohort Study.

Neurology·2026
Same journal

Role of the Upper Motor Neuron in the Generation of Fasciculations in Early Disease Stages of Amyotrophic Lateral Sclerosis.

Neurology·2026
Same journal

Factors Associated With Disability Improvement and Worsening Independent of Attacks in Patients With AQP4-IgG+ NMOSD and MOGAD: A Multicenter Cohort Study.

Neurology·2026
Same journal

Cost-Effectiveness of Intracranial Aneurysm Screening: A Systematic Review.

Neurology·2026
Same journal

Rare Eating Epilepsy: Co-Occurrence of Focal Cortical Dysplasia and Gray Matter Heterotopia.

Neurology·2026
See all related articles

Many myasthenia gravis patients lack acetylcholine receptor antibodies. Seronegative individuals show similar clinical features and respond to treatments like thymectomy, indicating antibody presence isn't essential for diagnosis or therapy.

Area of Science:

  • Neurology
  • Immunology

Background:

  • Myasthenia gravis (MG) is an autoimmune disorder often associated with acetylcholine receptor (AChR) antibodies.
  • A subset of MG patients are seronegative for AChR antibodies, posing diagnostic and therapeutic challenges.

Purpose of the Study:

  • To investigate the prevalence and clinical characteristics of seronegative myasthenia gravis.
  • To assess the impact of antibody status on treatment response in MG patients.

Main Methods:

  • Retrospective analysis of 221 myasthenia gravis patients.
  • Categorization based on antibody status (seropositive vs. seronegative) and clinical presentation (ocular vs. generalized).
  • Comparison of clinical features and treatment outcomes between seropositive and seronegative groups.

Related Experiment Videos

Main Results:

  • 18.5% of MG patients were seronegative for AChR antibodies.
  • Seronegative rates were 50% in patients with purely ocular symptoms for over 2 years and 17% in generalized MG.
  • Clinical characteristics were similar between seronegative and seropositive patients.
  • No thymoma was found in seronegative patients, though not statistically significant.
  • Lack of antibodies did not prevent positive responses to thymectomy or plasmapheresis.

Conclusions:

  • A significant proportion of myasthenia gravis patients are seronegative for acetylcholine receptor antibodies.
  • Seronegative myasthenia gravis patients exhibit comparable clinical features to seropositive patients.
  • Antibody status does not appear to influence the efficacy of treatments like thymectomy and plasmapheresis in myasthenia gravis.